-
Comprehensive Clinical Evaluation of Amphotericin B in the Treatment of Invasive Fungal Disease in China
Sep 9, 2025, 16:22 PM -
Deliverables From 10 Years' Implementation of a National Health Technology Assessment System: Outcomes Sustainability Efficiency, Access, and Equity
Sep 9, 2025, 16:22 PM -
Pain-Related Disparities in Healthcare Expenditures Among Individuals With Cancer Evidence From the United States Medical Expenditure Panel Survey
Sep 9, 2025, 16:22 PM -
Are We Getting Good Value for Innovative Therapies in the US? Findings From Generalized Cost-Effectiveness Analyses (GCEAs)
Sep 9, 2025, 16:22 PM -
Protocol for a Health Preference Study on Digital Health Interventions: Integrating DCE and BWS to Capture Subject, Interaction, System, and Societal Value
Sep 9, 2025, 16:22 PM -
The Natural History of Pancreatic Cancer and the Effectiveness of Screening a Model-Based Analysis
Sep 9, 2025, 16:22 PM -
Comparison of Persistence Rates: Tildrakizumab vs. Adalimumab/Ustekinumab Based on a German Longitudinal Prescription Database (LRx) of Social Health Insurance Patients in Outpatient Care
Sep 9, 2025, 16:22 PM -
Healthcare Resource Use Among Patients With Chronic Rhinosinusitis With Nasal Polyps in the United Kingdom: Results of an Expert Elicitation Survey
Sep 9, 2025, 16:22 PM -
Evaluating the Cost-Effectiveness of High-Dose Influenza Vaccination for Adults Aged 60 Years and Older in Austria
Sep 9, 2025, 16:22 PM -
Using Expert Consensus to Expand Access in Rare Disease Populations: Generating Evidence for Patients With Permanently Ventilated Spinal Muscular Atrophy
Sep 9, 2025, 16:22 PM -
Improving Efficiency in Evidence Synthesis: Performance Assessment of Machine Learning Classifiers for Automated Screening in Systematic Literature Reviews
Sep 9, 2025, 16:22 PM -
Assessing Pharmaceutical Innovation in Europe: Therapeutic Advances vs. Unmet Public Health Need
Sep 9, 2025, 16:22 PM -
Evaluating the Economic Burden of Polycythemia Vera Across the Disease Continuum: A Systematic Literature Review
Sep 9, 2025, 16:22 PM -
Early Stage Health Economic Evaluation of IMMUTOL Gene Therapy for Relapsing/Remitting Multiple Sclerosis in the Netherlands
Sep 9, 2025, 16:22 PM -
The Public Health and Economic Effects of Various RSV Vaccination Strategies With RSVpreF Among Adults in France
Sep 9, 2025, 16:22 PM -
Transparency Tested: Conflict of Interest in EU HTA
Sep 9, 2025, 16:22 PM -
Gene Expression Profiling Tests to Guide Adjuvant Chemotherapy Decisions in Lymph Node-Positive Early Breast Cancer: A Systematic Review
Sep 9, 2025, 16:22 PM -
Real-World Treatment Patterns Among Patients With Relapsed or Refractory (R/R) NPM1 Mutated (NPM1m) Acute Myeloid Leukemia (AML) in the United States (US)
Sep 9, 2025, 16:22 PM -
An AI-Powered Tool to Identify and Assess Fit-for-Use Registries for Drug Development and Evaluation
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of an AI-Based Smartphone App for the Early Detection of Skin Cancer: A Decision Tree Analysis
Sep 9, 2025, 16:22 PM
